Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. [electronic resource] by
- Young, J C
- Wu, S
- Hansteen, G
- Du, C
- Sambucetti, L
- Remiszewski, S
- O'Farrell, A-M
- Hill, B
- Lavau, C
- Murray, L J
Producer: 20060216
In:
Cytotherapy vol. 6
Availability: No items available.
|
|
47.
|
|
|
48.
|
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer. [electronic resource] by
- Sturrock, M
- Miller, I S
- Kang, G
- Hannis Arba'ie, N
- O'Farrell, A C
- Barat, A
- Marston, G
- Coletta, P L
- Byrne, A T
- Prehn, J H
Producer: 20191021
In:
Scientific reports vol. 8
Availability: No items available.
|
|
49.
|
Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer. [electronic resource] by
- Sturrock, M
- Miller, I S
- Kang, G
- Arba'ie, N Hannis
- O'Farrell, A C
- Barat, A
- Marston, G
- Coletta, P L
- Byrne, A T
- Prehn, J H
Publication details: Scientific reports Sep 2018
In:
Scientific reports vol. 8
Availability: No items available.
|
|
50.
|
The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus. [electronic resource] by
- Garcia-Soria, G
- Gonzalez-Galvez, G
- Argoud, G M
- Gerstman, M
- Littlejohn, T W
- Schwartz, S L
- O'Farrell, A-M
- Li, X
- Cherrington, J M
- Bennett, C
- Guler, H-P
Producer: 20080728
In:
Diabetes, obesity & metabolism vol. 10
Availability: No items available.
|
|
51.
|
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). [electronic resource] by
- Schittenhelm, M M
- Yee, K W H
- Tyner, J W
- McGreevey, L
- Haley, A D
- Town, A
- Griffith, D J
- Bainbridge, T
- Braziel, R M
- O'Farrell, A-M
- Cherrington, J M
- Heinrich, M C
Producer: 20061205
In:
Leukemia vol. 20
Availability: No items available.
|
|
52.
|
Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design. [electronic resource] by
- Hotho, Daphne M
- de Bruijne, Joep
- O'Farrell, A Marie
- Boyea, Teresa
- Li, Jianke
- Bracken, Michele
- Li, Xin
- Campbell, David
- Guler, Hans-Peter
- Weegink, Christine J
- Schinkel, Janke
- Molenkamp, Richard
- van de Wetering de Rooij, Jeroen
- van Vliet, Andre
- Janssen, Harry L A
- de Knegt, Robert J
- Reesink, Hendrik W
Producer: 20120723
In:
Antiviral therapy vol. 17
Availability: No items available.
|